Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Interest Expenses (2022 - 2025)

Cannabis Bioscience International Holdings' Interest Expenses history spans 4 years, with the latest figure at $17860.0 for Q4 2025.

  • For Q4 2025, Interest Expenses rose 59.46% year-over-year to $17860.0; the TTM value through Nov 2025 reached $21689.0, down 86.28%, while the annual FY2024 figure was $154206.0, 69.51% up from the prior year.
  • Interest Expenses for Q4 2025 was $17860.0 at Cannabis Bioscience International Holdings, up from $17368.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $95302.0 in Q2 2024 and bottomed at -$33513.0 in Q2 2025.
  • The 4-year median for Interest Expenses is $17614.0 (2025), against an average of $21272.5.
  • The largest annual shift saw Interest Expenses skyrocketed 7802.32% in 2024 before it tumbled 135.17% in 2025.
  • A 4-year view of Interest Expenses shows it stood at $36278.0 in 2022, then decreased by 8.95% to $33030.0 in 2023, then tumbled by 66.09% to $11200.0 in 2024, then skyrocketed by 59.46% to $17860.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Interest Expenses are $17860.0 (Q4 2025), $17368.0 (Q3 2025), and -$33513.0 (Q2 2025).